PRHSX
Price
$84.91
Change
+$1.04 (+1.24%)
Updated
Jan 30 closing price
Net Assets
13.5B
SHPAX
Price
$19.94
Change
+$0.09 (+0.45%)
Updated
Jan 30 closing price
Net Assets
11.18M
Ad is loading...

PRHSX vs SHPAX

Header iconPRHSX vs SHPAX Comparison
Open Charts PRHSX vs SHPAXBanner chart's image
T. Rowe Price Health Sciences
Price$84.91
Change+$1.04 (+1.24%)
VolumeN/A
Net Assets13.5B
Saratoga Health & Biotechnology A
Price$19.94
Change+$0.09 (+0.45%)
VolumeN/A
Net Assets11.18M
PRHSX vs SHPAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PRHSX vs. SHPAX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRHSX is a StrongBuy and SHPAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PRHSX has more cash in the bank: 13.5B vs. SHPAX (11.2M). PRHSX (0.00) and SHPAX (0.00) have matching dividends . PRHSX was incepted earlier than SHPAX: PRHSX (29 years) vs SHPAX (26 years). SHPAX is a more actively managed with annual turnover of: 58.00 vs. PRHSX (48.40). SHPAX has a lower initial minimum investment than PRHSX: SHPAX (250) vs PRHSX (2500). SHPAX annual gain was more profitable for investors over the last year : 2.27 vs. PRHSX (-5.33). PRHSX return over 5 years is better than : 7.16 vs. SHPAX (-0.25).
PRHSXSHPAXPRHSX / SHPAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years26 years-
Gain YTD6.7655.641120%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets13.5B11.2M120,536%
Annual Yield % from dividends0.000.00-
Returns for 1 year-5.332.27-235%
Returns for 3 years-6.880.10-6,820%
Returns for 5 years7.16-0.25-2,852%
Returns for 10 years19.66-34.21-57%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MACHX20.790.09
+0.43%
MoA Balanced Fund
HEMRX9.250.03
+0.33%
Janus Henderson Emerging Markets N
MFRHX59.17N/A
N/A
MFS Research R3
MRBVX16.23N/A
N/A
BlackRock Large Cap Focus Value R
FIKBX38.46N/A
N/A
Fidelity Advisor Financials Z